Z-Ala-Ala-Asn-AMC

目录号: PL08555 纯度: ≥99%
Z-Ala-Ala-Asn-AMC (Cbz-Ala-Ala-Asn-AMC) 是一种豆蔻素底物。293 HEK-Leg 细胞中过表达的豆蔻素有效裂解 CBZ-Ala-Ala-Asn-AMC。
CAS No. :149697-16-5
商品编号 规格 价格 会员价 是否有货 数量
PL08555-1mg 1mg ¥2250.00 请登录
PL08555-5mg 5mg ¥5464.00 请登录
PL08555-10mg 10mg ¥10125.00 请登录
PL08555-50mg 50mg 询价 询价
PL08555-100mg 100mg 询价 询价
PL08555-10mM*1mLinDMSO 10mM*1mLinDMSO ¥6798.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Z-Ala-Ala-Asn-AMC
英文名称
Z-Ala-Ala-Asn-AMC
英文别名
L-Aspartamide,N-[(phenylmethoxy)carbonyl]-L-alanyl-L-alanyl-N1-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-;L-Aspartamide,N-[(phenylmethoxy)carbonyl]-L-alanyl-L-alanyl-N1-(4-methyl-2-oxo-2H-1-benzopyran...;Z-ALA-ALA-ASN-AMC;Z-Ala-Ala-Asn-MCA;BENZYLOXYCARBONYL-L-ALANYL-L-ALANYL-L-ASPARAGINE 4-METHYLCOUMARYL-7-AMIDE;Z-AAN-AMC;benzyl N-[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[(4-methyl-2-oxochromen-7-yl)amino]-1,4-dioxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamate;starbld0000904;Z - ALA - ALA - ASN - AMC;benzyloxycarbonyl-Ala-Ala-Asn-4-methyl-7-coumarylamide;Z-Ala-Ala-Asn-AMC
Cas No.
149697-16-5
分子式
C28H31N5O8
分子量
565.57
包装储存
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
详情描述
Z-Ala-Ala-Asn-AMC (Cbz-Ala-Ala-Asn-AMC) 是一种豆蔻素底物。293 HEK-Leg 细胞中过表达的豆蔻素有效裂解 CBZ-Ala-Ala-Asn-AMC。
产品详情
Z-Ala-Ala-Asn-AMC (Cbz-Ala-Ala-Asn-AMC) 是一种豆蔻素底物。293 HEK-Leg 细胞中过表达的豆蔻素有效裂解 CBZ-Ala-Ala-Asn-AMC。
生物活性
Z-Ala-Ala-Asn-AMC (Cbz-Ala-Ala-Asn-AMC) is the legumain substrate. Overexpressed legumain in 293 HEK-Leg cells potently cleaved CBZ-Ala-Ala-Asn-AMC.
性状
Solid
体外研究(In Vitro)
The first legumain fluorogenic substrate Cbz-Ala-Ala-Asn-AMC based on the P3-P2-P1 sequence Ala-Ala-Asn. The synthetic substrate Cbz-Ala-Ala-Asn-AMC is effectively cleaved by S. mansoni legumain and human legumain with Kms of 90 and 80 uM respectively. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
参考文献
[1]. Stern L, Perry R, Ofek P, Many A, Shabat D, Satchi-Fainaro R. A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain. Bioconjug Chem. 2009;20(3):500-510.
[2]. James C. Powers, et al. Propenoyl hydrazides. US7482379B2.
[3]. Poreba M, et al. Counter Selection Substrate Library Strategy for Developing Specific Protease Subst
溶解度数据
In Vitro: DMSO : 50 mg/mL (88.41 mM; Need ultrasonic)H2O : < 0.1 mg/mL (ultrasonic) (insoluble)配制储备液
搜索质检报告(COA)
[1]. Stern L, Perry R, Ofek P, Many A, Shabat D, Satchi-Fainaro R. A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain. Bioconjug Chem. 2009;20(3):500-510.
[2]. James C. Powers, et al. Propenoyl hydrazides. US7482379B2.
[3]. Poreba M, et al. Counter Selection Substrate Library Strategy for Developing Specific Protease Subst

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2